| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/18/2000 | CA2093927C Ligand-mediated immunofunctional hormone binding protein assay method |
| 07/18/2000 | CA2011031C Plasmodium merozoite rhoptries antigen and derivatives thereof |
| 07/18/2000 | CA1341052C Cellular encapsulation of biological pesticides |
| 07/13/2000 | WO2000040958A1 Heat-sensitive medium for separating species in a separator channel |
| 07/13/2000 | WO2000040760A1 Silent inducible virus replicons and uses thereof |
| 07/13/2000 | WO2000040759A2 Uses of flavivirus rna-dependent rna polymerases |
| 07/13/2000 | WO2000040757A2 Method of identifying nucleic acids |
| 07/13/2000 | WO2000040756A1 Novel coactivator overexpressed in endocrine tumors |
| 07/13/2000 | WO2000040755A2 Method for accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing |
| 07/13/2000 | WO2000040753A1 Fluorescent intensity assay for protein or peptide binding to nucleic acids |
| 07/13/2000 | WO2000040751A2 Detecting nucleic acids |
| 07/13/2000 | WO2000040750A1 Method for sequencing dna using a microfluidic device |
| 07/13/2000 | WO2000040745A1 Prokaryotic system designed to monitor protease activity |
| 07/13/2000 | WO2000040744A1 Method for screening for inhibitors of riboflavin biosynthesis |
| 07/13/2000 | WO2000040742A1 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 07/13/2000 | WO2000040741A2 Lentivirus vector system |
| 07/13/2000 | WO2000040740A2 Gene therapy to promote angiogenesis |
| 07/13/2000 | WO2000040739A2 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF |
| 07/13/2000 | WO2000040738A1 Co-expression of proteins |
| 07/13/2000 | WO2000040737A1 High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 07/13/2000 | WO2000040736A2 Molecular-biological marker for analytical electron microscopy |
| 07/13/2000 | WO2000040735A1 Construct of recombinant nucleic acids circularised by dna compacting agents |
| 07/13/2000 | WO2000040734A1 Recombinant herpes simplex virus useful for treating neoplastic disease |
| 07/13/2000 | WO2000040733A1 Human cyclic nucleotide pdes |
| 07/13/2000 | WO2000040732A1 Variant luciferase, variant luciferase gene, novel recombinant dna and process for producing variant luciferase |
| 07/13/2000 | WO2000040731A1 Thermostable firefly luciferases, thermostable firefly luciferase genes, novel recombinant dna and process for producing thermostable firefly luciferase |
| 07/13/2000 | WO2000040730A1 POLYHYDROXYALKANOATE BIOSYNTHESIS ASSOCIATED PROTEINS AND CODING REGION IN $i(BACILLUS MEGATERIUM) |
| 07/13/2000 | WO2000040729A1 Streptococcal abc transporter protein |
| 07/13/2000 | WO2000040728A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity |
| 07/13/2000 | WO2000040727A2 Recombinant growth factor with the biological activity of a g-csf (granulocyte colony stimulating factor) |
| 07/13/2000 | WO2000040726A1 Human chemokine beta-10 mutant polypeptides |
| 07/13/2000 | WO2000040725A1 Screening method |
| 07/13/2000 | WO2000040724A1 Human seven-transmembrane receptors |
| 07/13/2000 | WO2000040723A2 Methods and products for delivering nucleic acids |
| 07/13/2000 | WO2000040722A2 Insulin-synthesis genes |
| 07/13/2000 | WO2000040721A1 Monocyte-derived nucleic acids and related compositions and methods |
| 07/13/2000 | WO2000040720A1 Cells for measuring ability to promote transcription |
| 07/13/2000 | WO2000040719A2 Tissue repair protein involved in orofacial clefting and uses thereof |
| 07/13/2000 | WO2000040718A2 MUTANTS OF GNRPs AND VECTORS SUITABLE FOR THEIR EXPRESSION |
| 07/13/2000 | WO2000040717A1 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 07/13/2000 | WO2000040716A2 Soluble receptor br43x2 and methods of using them for therapy |
| 07/13/2000 | WO2000040715A2 Improved nucleic acid cloning |
| 07/13/2000 | WO2000040714A2 Therapeutic phosphodiesterase inhibitors |
| 07/13/2000 | WO2000040712A1 Optical sorting method |
| 07/13/2000 | WO2000040710A2 Seed-preferred promoter |
| 07/13/2000 | WO2000040709A2 Process for altering plant synthesis in plants using modified trnas |
| 07/13/2000 | WO2000040708A1 Thermostable creatine amidinohydrolase and process for producing the same |
| 07/13/2000 | WO2000040707A1 Modified forms of hepatitis c virus ns3 protease |
| 07/13/2000 | WO2000040706A1 Process for producing transglutaminase |
| 07/13/2000 | WO2000040705A2 Human desaturase gene and uses thereof |
| 07/13/2000 | WO2000040704A1 Bleomycin gene cluster components and their uses |
| 07/13/2000 | WO2000040699A2 Astrocytes, their preparation and uses thereof |
| 07/13/2000 | WO2000040698A1 Pth receptor and screening assay utilizing the same |
| 07/13/2000 | WO2000040697A1 Methods and compositions for isolation of nucleic acid molecules |
| 07/13/2000 | WO2000040695A2 Sequence-determined dna fragments and corresponding polypeptides encoded thereby |
| 07/13/2000 | WO2000040694A2 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 07/13/2000 | WO2000040693A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 07/13/2000 | WO2000040692A2 Methods and compositions for delivering nucleic acids |
| 07/13/2000 | WO2000040616A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41 |
| 07/13/2000 | WO2000040615A2 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS |
| 07/13/2000 | WO2000040614A2 Characterization of the soc/crac calcium channel protein family |
| 07/13/2000 | WO2000040613A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040612A1 Insulin-like growth factor (igf) i mutant variants |
| 07/13/2000 | WO2000040610A1 Process for producing activated protein |
| 07/13/2000 | WO2000040607A2 Tiam2 (t-cell lymphoma invasion and metastasis 2) nucleotide exchange factor |
| 07/13/2000 | WO2000040606A2 Modulation of hiv replication using sam68 |
| 07/13/2000 | WO2000040603A2 Production of recombinant monellin using methylotrophic yeast expression system |
| 07/13/2000 | WO2000040596A1 Gene cluster for production of the enediyne antitumor antibiotic c-1027 |
| 07/13/2000 | WO2000040595A1 Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| 07/13/2000 | WO2000040593A2 Target molecule attachment to surfaces |
| 07/13/2000 | WO2000040592A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof |
| 07/13/2000 | WO2000040591A1 Protonated/acidified nucleic acids and methods of use |
| 07/13/2000 | WO2000040334A1 Fiber array for contacting chemical species and methods for using and making same |
| 07/13/2000 | WO2000040274A1 Metastasis models using green fluorescent protein (gfp) as a marker |
| 07/13/2000 | WO2000040271A2 P450 / acetaminophen gdept for cancer treatment |
| 07/13/2000 | WO2000031268B1 Maize rad23 genes and uses thereof |
| 07/13/2000 | WO2000026392A3 MUTANT MOUSE CONTAINING A KNOCKOUT MUTATION IN DNA ENCODING AN ENDOGENOUS α4 SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR |
| 07/13/2000 | WO2000024914A3 Apomixis conferred by expression of serk interacting proteins |
| 07/13/2000 | WO2000024897B1 Cell surface molecule-induced macrophage activation |
| 07/13/2000 | WO2000024246A3 Transgenic fish carrying plasmid for mutation detection and methods |
| 07/13/2000 | WO2000023091A3 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 07/13/2000 | WO2000022121A3 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/13/2000 | WO2000022118A3 Non-desensitizing ampa-receptors |
| 07/13/2000 | WO2000022092A3 Materials and methods for the modification of plant cell wall polysaccharides |
| 07/13/2000 | WO2000021987A3 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 07/13/2000 | WO2000021986A3 Matrix-remodeling genes |
| 07/13/2000 | WO2000020445A3 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/13/2000 | WO2000018801A3 Ncam binding compounds |
| 07/13/2000 | WO2000018351A3 Aglyco products and methods of use |
| 07/13/2000 | WO2000017642A3 Biological applications of semiconductor nanocrystals |
| 07/13/2000 | WO2000017366A3 Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug |
| 07/13/2000 | WO2000017364A3 Cyclin d polynucleotides, polypeptides and uses thereof |
| 07/13/2000 | WO2000017321A3 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering |
| 07/13/2000 | WO2000015800A3 Rac-like genes and methods of use |
| 07/13/2000 | WO2000015799A3 Rna-associated proteins |
| 07/13/2000 | WO2000014276A9 Oligo nucleotides, method and kit for detecting listeria monocytogenes by amplifying and/or hybridizing nucleic acids |
| 07/13/2000 | WO2000014247B1 Agents and methods for modifying the glutamine metabolism in plants, especially in sugar beet |
| 07/13/2000 | WO2000014217A3 G-motif oligonucleotides and uses thereof |
| 07/13/2000 | WO2000012735A9 Transgene assay using stable agrobacterium rhizogenes transformation |
| 07/13/2000 | WO2000012705A9 Methods for improving the function of heterologous g protein-coupled receptors |